Racial disparities in colorectal cancer (CRC) screening are frequently attributed to variations in insurance status. The objective of this study was to ascertain whether universal insurance would lead to more equitable utilization of CRC screening for black patients in comparison with white patients. METHODS: Claims data from TRICARE (insurance coverage for active, reserve, and retired members of the US Armed Services and their dependents) for 2007-2010 were queried for adults aged 50 years in 2007, and they were followed forward in time for 4 years (ages, 50-53 years) to identify their first lower endoscopy and/or fecal occult blood test (FOBT). Variations in CRC screening were compared with descriptive statistics and multivariate logistic regression. RESULTS: Among the 24,944 patients studied, 69.2% were white, 20.3% were black, 4.9% were Asian, and 5.6% were other. Overall, 54.0% received any screening: 83.7% received endoscopy, and 16.3% received FOBT alone. Compared with whites, black patients had higher screening rates (56.5%) and had 20% higher risk-adjusted odds of being screened (95% confidence interval [CI], 1.11-1.29). Asian patients had a likelihood of screening similar to that of white patients (odds ratio [OR], 1.06; 95% CI, 0.92-1.23). Females (OR, 1.20; 95% CI, 1.10-1.33), active-duty personnel (OR, 1.15; 95% CI, 1.06-1.25), and officers (OR, 1.28; 95% CI, 1.18-1.37) were also more likely to be screened. CONCLUSION: Within an equal-access, universal health care system, black patients had higher rates of CRC screening in comparison with prior reports and even in comparison with white patients within the population. These findings highlight the need to understand and develop meaningful approaches for promoting more equitable access to preventative care. Moreover, equal-access, universal health insurance for both the military and civilian populations can be presumed to improve access for underserved minorities.
INTRODUCTION
Colorectal cancer (CRC) is a leading cause of mortality and morbidity in the United States, with more than 50,000 deaths and 100,000 cases reported annually. 1 Appropriate screening represents an important measure for promoting earlier diagnosis, reducing advanced-stage disease, and improving mortality. [2] [3] [4] The US Preventive Services Task Force recommends that colorectal screening begin at the age of 50 years for average-risk individuals. 5 Despite these guidelines, the rates of colonoscopy and fecal occult blood test (FOBT) screening have remained suboptimal in the United States, with reported overall rates ranging from 58.6% to 64.5%. 6, 7 Screening rates are even lower among racial/ethnic minority groups, with rates as low as 30% being reported for black and Asian patients. 8, 9 Among the uninsured, rates plummet further, with reports estimating them to be approximately 21%-far below the Healthy People 2020 target of 70.5%. 10 Racial disparities in CRC screening are a major public health concern. Studies have shown that black patients have a higher incidence of and higher mortality from CRC in comparison with white patients. For example, cancer statistics from 2012 indicate that 66.9 per 100,000 black male patients are diagnosed with CRC, whereas 54.6 per 100,000 white male patients are; 30.5 per 100,000 black males die of CRC, whereas 20.1 per 100,000 white males do. 1, 11 Lower rates of screening among black patients have also been shown to be associated with an advanced stage of presentation and resultant higher mortality among black patients in comparison with white patients. [12] [13] [14] The reasons for these screening disparities are multifactorial. Prior research has suggested associations with insurance, socioeconomic status (SES),
Cancer September 15, 2018 education, and a patient's source of care. 2, 8, 15, 16 Although insurance has been postulated to be a primary reason for the existence of CRC screening disparities, studies among universally insured Medicare populations have demonstrated the persistence of these disparities despite ensured payment coverage. 9, [17] [18] [19] Although Medicare accounts for screening trends among adults older than 64 years, it does not include people aged 50 to 64 years who are eligible for screening. This latter group represents an important population to target to reduce CRC incidence and mortality. In contrast to higher rates of screening and more equitable outcomes demonstrated in Medicare data, studies show that CRC screening rates are lowest among adults aged 50 to 64 years. 20, 21 There is a need to understand what factors influence screening utilization in this population. The effect of universal insurance on such adults is also unclear. However, in a previous survey study from the US Department of Defense health care program, which was designed to provide equal access and treatment to military personnel and their families, minorities selfreported greater or equal receipt of other preventative services, such as mammograms and Papanicolaou smears, in comparison with white patients. 22 For CRC screening, the self-reported rate was higher among black patients in the military health care system in comparison with black patients in the civilian setting (58% vs 49%); however, this difference was not statistically significant. Although this was a survey-based study using patient-reported responses, this prior study highlighted several potential ways in which universal insurance may improve racial disparities in health care. In this context, the objective of this study was to use administrative insurance claims data to classify patterns of CRC screening within a national subset of the US population that is universally insured from the age of 50 years with a specific focus on potential differences in screening rates between black and white patients.
MATERIALS AND METHODS

Data Set
We queried the Military Health System (MHS) Data Repository for TRICARE insurance claims data provided by the Department of Defense. TRICARE insurance is the US military's universal medical coverage system. This provides coverage for all active military personnel, retirees from the military, members of the National Guard and National Reserves, and their dependents. 23, 24 Through TRICARE, beneficiaries receive comprehensive care either through a network of military hospitals and clinics (direct care) or through civilian hospitals and providers (purchased care). All care encounters are captured within TRICARE claims data, regardless of whether they occurred at a military or civilian hospital. The MHS TRICARE system is distinct from the Veterans Health Administration (US Department of Veterans Affairs), which provides care for military veterans, including those who have completed less than 20 years of active-duty service. 25 The population included in the TRICARE database has been previously shown to be similar in sociodemographic profile to the general civilian US population. 22, 26 We identified TRICARE beneficiaries who were 50 years old in 2007 and followed them forward for 3 years until December 2010. We identified their first screening colonoscopy, flexible sigmoidoscopy, and/or FOBT that occurred during that time on the basis of Current Procedural Terminology procedure codes (82270, 82274, and G0328 for FOBT; 45330, 45331, 45333, 45338, 45339, and G0104 for sigmoidoscopy; and 45378, 45380, 45383, 45384, 45385, and G0121 for colonoscopy). Colonoscopy and sigmoidoscopy were grouped into an endoscopy group. The primary outcome of the study was the receipt of any type of CRC screening procedure.
Our primary exposure of interest was self-reported or TRICARE sponsor-reported race, which was categorized as white, black, Asian (including Pacific Islanders), and other (including American Indians and Alaskan Natives). These 4 race categorizations did not include further subclassifications by ethnicity. We also abstracted demographic and clinical case-mix information on identified patients, including sex, beneficiary category, self or sponsor service, type of care/facility where the screening procedure was performed (direct or purchased), self or sponsor rank, and geographical region of residence. For patients who did not receive any CRC screening procedure, the type of care facility was determined from other health care encounters during the study period.
Patients with missing demographic or clinical information, incomplete follow-up in TRICARE, or a prior screening procedure before the age of 50 years were excluded. Patients who had an increased likelihood of undergoing a diagnostic endoscopy or FOBT due to any prior diagnosis of diverticulitis, inflammatory bowel disease (including ulcerative colitis or Crohn's disease), or benign/malignant lesions of the colon were also excluded on the basis of International Classification of Diseases, Ninth Revision, codes gathered from both inpatient and outpatient encounters. Before their exclusion for missing
Cancer September 15, 2018 race data, patients with missing race data but all other reported covariables were used to calculate the inverse probability that race was reported on the basis of other available demographic data. These weights were used to weight remaining observations to account for potential biases associated with missing race information; this technique, known as reweighting estimating equations, has been previously shown to provide the least biased approach for handling missing race in large databases. 27 Aschematic of inclusion/exclusion criteria is presented in Figure 1 .
Data Analysis
A descriptive analysis of the patient demographics, beneficiary category, self/sponsor service, self/sponsor rank, and region was performed in which we compared CRC screening rates. Categorical variables were compared with Pearson chi-square tests. Kruskal-Wallis tests were used for nonnormally distributed continuous ages. Similar analyses were conducted on individual screening procedures-endoscopy and FOBT-to compare the rates. Using unweighted complete-case observations, we also conducted a sensitivity analysis to test reweighting estimating equation assumptions and found similar results.
Bivariate and multivariate logistic regression models were built to assess the likelihood of receiving any type of screening. Covariables included in the multivariate model were selected on the basis of predictors of screening behavior as well as statistically significant differences between the racial groups.
2 Models yielded adjusted odds ratios (ORs) and corresponding 95% confidence intervals (CIs). All P values were 2-sided, with P < .05 considered significant. Data were analyzed with Stata statistical software (release 14.1). The Partners Human Research Committee, the institutional review board of Partners HealthCare (Brigham and Women's Hospital/Massachusetts General Hospital), and the Uniformed Services University of the Health Sciences institutional review board approved the study.
RESULTS
Overall, 24,944 enrollees met the study inclusion criteria. The cohort was predominantly composed of male (66.1%, n = 16,493), married (89.0%, n = 22,187), retired (58.7%, n = 14,635), and enlisted self/sponsor rank (72.2%, n = 18,003) TRICARE enrollees ( Table 1) . Most patients in this study were from the TRICARE South region (63.1%, n = 15,735) and underwent their screening procedure at military hospitals (direct-care system; 64.7%, n = 16,129).
Most enrollees were white (69.2%, n = 17,258); the rest were categorized as black (20.3%, n = 5062), Asian (5.0%, n = 1234), and other (5.6%, n = 1390; Table 1 ). White and black enrollees were more likely to be male (69.9% and 64.4%, respectively), retired (60.5% and 63.6%, respectively), and from the South (59.7% and 80.7%, respectively). Asian enrollees were more likely to be female (52.7%, n = 650), dependents (46.4%, n = 572), Cancer September 15, 2018 and from the West (53.9%, n = 665). There were significantly fewer white enlisted enrollees (67.4%, n = 11,623) in comparison with black (84.4%, n = 4274) or Asian enlisted enrollees (84.4%, n = 1017).
Patterns of CRC Screening
Within our study sample, the percentage of enrollees receiving any type of screening was 54.0% (n = 13,479). As for the screening procedures, the percentage of enrollees receiving endoscopy was 45.2% (n = 11,279), and the percentage receiving only FOBT screening was 8.8% (n = 2200; Table 2 ). Black enrollees had slightly higher CRC screening rates (56.5%, n = 2862) than white (53.5%, n = 9239) or Asian enrollees (52.9%, n = 653; P < .001). Similarly, rates of endoscopy screening were higher among black enrollees (47.3%, n = 2393) than white enrollees (45.1%, n = 7790) and Asian enrollees (41.4%, n = 511; P < .05). Among patients who had only FOBT screening, Asian enrollees had the highest rates (11.5%, n = 142), and they were followed by black enrollees (9.3%, n = 469) and then white enrollees (8.4%, n = 1449). Among all races, the age at first screening among patients who underwent endoscopy screening was younger with a median age of 50.9 years in comparison with the age of those receiving FOBT screening with a median age of 52.9 years. Overall screening rates were highest among female (55.5%, n = 4690) and active-duty enrollees (56.8%, n = 2056; Table 2 ). Enrollees of officer self/sponsor rank had the highest CRC screening rates (58.1%, n = 3298), and they were followed by other enrollees (55.5%, n = 702) and then enlisted enrollees (52.7%, n = 9479). There were statistically significant variations in endoscopy screening rates, with the highest rates found in active-duty personnel (48.6%), married enrollees (45.5%), and officers (48.8%) and in the South (46.3%). For FOBT screening, there were significant variations in rates, with the highest found among female patients (10.2%), enrollees living in the West (9.6%), and enrollees receiving care in civilian hospitals (10.1%). The numbers in parentheses are the row percentages.
Cancer September 15, 2018 The adjusted odds for the receipt of CRC screening are presented in Table 3 . Black enrollees had 14% higher odds of undergoing CRC screening in comparison with white enrollees (OR, 1.14; 95% CI, 1.06-1.23); this number increased to 20% after risk adjustment (OR, 1.20; 95% CI, 1.11-1.29; Table 3 ). Female enrollees had 20% higher odds of receiving screening (adjusted OR, 1.20; 95% CI, 1.10-1.33). Single enrollees had lower odds of receiving screening in comparison with married enrollees (adjusted OR, 0.88; 95% CI, 0.80-0.97). Active-duty enrollees had 15% higher odds of receiving CRC screening in comparison with retired enrollees (adjusted OR, 1.15; 95% CI, 1.06-1.25). Enrollees of officer sponsor rank had higher odds of receiving screening in comparison with enlisted enrollees (adjusted OR, 1.28; 95% CI, 1.18-1.37). Theodds of CRC screening were 13% higher among patients managed at civilian hospitals versus military hospitals (adjusted OR, 1.13; 95% CI, 1.07-1.20). Additional unadjusted results are presented in Table 3 .
DISCUSSION
The literature reports significantly lower rates of CRC screening among minorities versus whites. 8, 9 Two of the major system-level factors that have been attributed to these racial disparities in screening are a lack of access and a lack of insurance coverage. 2, 8, 9, 15, 16 Timely screening is a critical component of reducing the morbidity and mortality of CRC. Despite recommendations for screening to begin at 50 years of age, approximately 40% of the overall at-risk population does not receive screening at an appropriate age. 6, 7 Minority patients within the universally insured population examined in this study were more likely to receive age-appropriate screening than a similar cohort of white patients. Unfortunately, the overall rate of screening across all races remained suboptimal at 54%. Differences in screening also continued to prevail by sex (OR for females vs males, 1.20; 95% CI, 1.10-1.33) and across socioeconomic strata (OR for officers vs enlisted, 1.28; 95% CI, 1.18-1.37).
Although other nationwide studies from the civilian setting have reported rates as low as 30% among black patients, we report a higher CRC screening rate of 56.5% among black patients within the military setting. 8 In this study, black patients demonstrated higher rates of screening in comparison with white patients (56.5% Cancer September 15, 2018 vs 53.5%) within the same universally insured, military setting. This is contrary to prior research with national survey data, which suggest that black patients have lower screening rates than white patients. With the Behavioral Risk Factor Surveillance System, lower screening rates for black patients older than 50 years, ranging from 55% to 59%, were found in comparison with the rates for white patients, which ranged from 60% to 62%. 6, 7, 28 The most commonly identified system-level barriers that affect CRC screening in the civilian population include a lack of access and a lack of insurance. Among black patients, insurance status and financial concerns have been identified as overwhelming barriers to health care preventative services. Data show that 13% to 23% of blacks are uninsured, whereas less than 10% of whites are. [29] [30] [31] [32] Within our study population, this barrier is eliminated because enrollees are universally provided insurance. We hypothesize that the higher rate of CRC screening among blacks reported in the current study in comparison with prior reports is due to universal health care insurance coverage. With the lack-of-insurance barrier eliminated in this study population, we identified a CRC screening rate among blacks of 56.5%, which is higher than nationally reported rates, which have been as low as 30%. Unfortunately, the screening rate among whites in this study (53.5%) remained comparable to civilian reported rates (58.5%). 22 Universal health care insurance does not address other significant barriers such as patients' lack of knowledge or awareness about the need for screening, patients' refusal to follow screening guidelines, and a lack of screening recommendations by a health care provider. 8, 33, 34 Additional targeted interventions are needed to improve screening among racial groups and subpopulations that may encounter these issues as their primary barriers to age-appropriate screening. [35] [36] [37] We acknowledge that people who join the military may not have the same barriers with health literacy because there is a selection process to join the military that requires minimum education levels.
Rank is often used as a proxy measure for SES within the military because annual salaries vary significantly across different ranks. 38, 39 Variations in screening according to SES continued to persist in the military health care system. This is consistent with prior research Cancer September 15, 2018 in the civilian population, which has reported persistent disparities based on education and income within other subpopulations with universal access, such as Medicare. 19, 40 Our study shows that officers, reflecting their higher SES, were more likely to be screened (OR, 1.28; 95% CI, 1.18-1.37) than enlisted service personnel. This finding again emphasizes the complex interaction with other social factors, in addition to race, insurance, and access, that contribute to these disparities. Although the provision of universal insurance and equal access may improve care for certain populations who identify a lack of insurance and access as their primary barriers, other population groups, such as those of lower SES, may continue to have additional barriers to health care.
The overall screening rate of 54.0% reported in our cohort is slightly lower than the average rates of 56.4% to 59.1% previously reported in the general population. 21 However, within the younger population (50-53 years) that constituted our study population, the screening rates we reported are higher than the national average for this age group. The Behavioral Risk Factor Surveillance System has reported significantly lower rates of screening (45%) among patients aged 50 to 54 years. 6 A lack of insurance through Medicare has been cited as one of the main reasons for the low rates in this age group in comparison with patients older than 65 years. 6, 15 The higher rates of screening seen in our study in comparison with national estimates further strengthen the argument that the provision of universal health care should help to increase screening and thereby contribute to reducing the overall rate of CRC by early polyp detection and removal. 41 This can also promote earlier diagnosis and reductions in advanced-stage disease and hopefully improve mortality. 2 There are several limitations to our study. Within this data set, there is a lack of clinical detail as well as the possibility of absent or incorrect coding of events. The identification of screening procedures and exclusion criteria relies on International Classification of Diseases, Ninth Revision, and Current Procedural Terminology codes, neither of which can differentiate diagnostic procedures from screening procedures; therefore, it is possible that we might not be capturing all screening tests at the expense of excluding diagnostic tests. Despite this, there is no reason to suspect that this would be biased as a function of race. To minimize potential biases due to these factors, our exclusion criteria attempted to identify only average-risk individuals who would have had an increased likelihood of having screening procedures versus diagnostic procedures. The study cohort was also specifically designed to capture a younger population eligible for screening and excluded in Medicare studies. It is also possible that enrollees may have had a screening test done with separate supplemental insurance. This would not be reflected in the TRICARE insurance claims data set. However, patients with TRICARE generally use it as their primary insurance.
In conclusion, within the universal insurance coverage provided through the military setting, black patients are more likely to receive age-appropriate CRC screening than white patients. Further exploration of patient, provider, and systemic factors prevalent in this population that are associated with improved health care access for racial minorities may help us to develop interventions for preventive services within the general US population. The hypothesis that universal access increases CRC screening, especially among minorities, is strongly supported by our analysis. In addition, we found significant rank-based disparities (a proxy for SES), with officers displaying better CRC screening outcomes than enlisted service personnel, and this suggests the need for further MHS interventions targeting barriers to screening that may covary with rank. Even though we studied only a specific subset of the US population, aspects of this study highlight the need to consider factors beyond insurance coverage when screening programs are being developed.
FUNDING SUPPORT
The Center for Surgery and Public Health is jointly supported in part with the Uniformed Services University of the Health Sciences by a grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine.
approval of the version to be published, and accountability for all aspects of the work. Tracey Koehlmoos: Conception and design of work, interpretation of data, writing-review and revisions, final approval of the version to be published, and accountability for all aspects of the work. Peter A. Learn: Conception and design of work, interpretation of data, writing-review and revisions, final approval of the version to be published, and accountability for all aspects of the work. Adil H. Haider: Conception and design of work, interpretation of data, writing-review and revisions, final approval of the version to be published, and accountability for all aspects of the work. Joel E. Goldberg: Conception and design of work, interpretation of data, writing-initial draft, writing-review and revisions, final approval of the version to be published, and accountability for all aspects of the work.
